Central Laboratory
Services
Every pioneer needs a partner.
When the FDA approves your clinical trial study, you must meet stringent deadlines to obtain funding and complete the study on time. With more than 25 years of experience, you can trust our team of experts to provide high-quality laboratory testing and personalized, meticulous service for your clinical research needs. TriCore Research Institute’s Central Lab Services (CLS) offers access to TriCore’s robust clinical laboratory testing capabilities at its CLIA, CAP LAP, and 15189 accredited Core Laboratory.
We have the same capabilities as large clinical laboratories, including an extensive test menu, a variety of testing platforms, decades of experience, efficient logistics and testing, kit production, and customizable data formats and reporting capabilities. We are able to accommodate all sizes of clinical research in an expedient manner. We collaborate with our clients to produce high-quality data that meets federal agencies' scrutiny during inspections.
With more than 50 pathologists and PhD scientists, TriCore provides expertise in all fields of pathology, including:
- Infectious Disease
- Clinical Chemistry & Toxicology
- Hematology & Coagulation
- Immunology
- Flow Cytometry
- Cytogenetics
- Molecular Diagnostics
- Cytology
- Histology
In addition to central lab testing capabilities, CLS offers our clients:
Clinical Trial Kits
We can provide and mail specimen collection kits to the clinical sites.
Resource Materials
If requested, lab manuals or instruction sheets for the collections can be provided.
Report Formats
We offer formats in excel, PDF, and CSV.
HOW WE WORK WITH YOU
Are you interested in receiving a central lab services proposal for your clinical research study? We understand your clinical study is ready to proceed, and sites and patients have already been identified. We understand the urgency and we want to collaborate with you for a successful clinical study. When you request a proposal, we will identify if we have the test capabilities and testing platforms, and review the proposed start date.
Insights
Point of Care Testing: A Blessing or a Burden?
Point-of-care testing (POCT) refers to medical diagnostic testing that is performed near the patient, often at the bedside, rather than in a centralized laboratory. This type of testing provides rapid results, allowing healthcare providers to make immediate treatment decisions. POCT devices are typically portable, easy to use, and require minimal training. They are suitable for…
New Areas of Discovery and Collaboration
Since its inception, TriCore’s Research Institute has experienced steady and continuous growth, emphasizing research in the field of infectious diseases. During the pandemic, the focus was on COVID Emergency Use Authorizations, which were crucial. The Institute is now diversifying to encompass more intricate studies, such as more complex COVID 510(k) submissions and other respiratory viruses….
TRI Partners with Sponsors for 510(k) Submissions
A 510(k) submission is a premarket submission made to the U.S. Food and Drug Administration (FDA) for the purpose of obtaining clearance to market a medical device or instrument in the United States. An in-vitro diagnostic (IVD) medical device manufacturer may need to submit a 510(k) application if it intends to introduce a new IVD…
We partner with organizations who continually strive to make scientific advances in healthcare. Connect with us and discover how we can help you with your clinical research needs.
"*" indicates required fields